United States Kidney Cancer Drug Market Report 2016

September 2016 | 115 pages | ID: UEFC617C579EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Kidney Cancer Drug

Revenue, means the sales value of Kidney Cancer Drug

This report studies sales (consumption) of Kidney Cancer Drug in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Bayer
• F. Hoffmann-La Roche
• GlaxoSmithKline
• Novartis
• Pfizer
• Abbott Laboratories
• Active Biotech
• Amgen
• Argos Therapeutics
• ArQule
• AVEO Pharmaceuticals
• Bionomics
• Bristol-Myers Squibb
• Cerulean Pharma
• Exelixis
• Genentech
• immatics biotechnologies
• Immunicum
• Ono Pharmaceutical
• Onyx Therapeutics
• Oxford BioMedica
• Prometheus Laboratories
• Seattle Genetics
• Taiwan Liposome
• TRACON Pharmaceuticals
• Wilex

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Kidney Cancer Drug in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Kidney Cancer Drug Market Report 2016

1 KIDNEY CANCER DRUG OVERVIEW

1.1 Product Overview and Scope of Kidney Cancer Drug
1.2 Classification of Kidney Cancer Drug
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Kidney Cancer Drug
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Kidney Cancer Drug (2011-2021)
  1.4.1 United States Kidney Cancer Drug Sales and Growth Rate (2011-2021)
  1.4.2 United States Kidney Cancer Drug Revenue and Growth Rate (2011-2021)

2 UNITED STATES KIDNEY CANCER DRUG COMPETITION BY MANUFACTURERS

2.1 United States Kidney Cancer Drug Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Kidney Cancer Drug Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Kidney Cancer Drug Average Price by Manufactures (2015 and 2016)
2.4 Kidney Cancer Drug Market Competitive Situation and Trends
  2.4.1 Kidney Cancer Drug Market Concentration Rate
  2.4.2 Kidney Cancer Drug Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES KIDNEY CANCER DRUG SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Kidney Cancer Drug Sales and Market Share by Type (2011-2016)
3.2 United States Kidney Cancer Drug Revenue and Market Share by Type (2011-2016)
3.3 United States Kidney Cancer Drug Price by Type (2011-2016)
3.4 United States Kidney Cancer Drug Sales Growth Rate by Type (2011-2016)

4 UNITED STATES KIDNEY CANCER DRUG SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Kidney Cancer Drug Sales and Market Share by Application (2011-2016)
4.2 United States Kidney Cancer Drug Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES KIDNEY CANCER DRUG MANUFACTURERS PROFILES/ANALYSIS

5.1 Bayer
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Kidney Cancer Drug Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Bayer Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 F. Hoffmann-La Roche
  5.2.2 Kidney Cancer Drug Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 F. Hoffmann-La Roche Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 GlaxoSmithKline
  5.3.2 Kidney Cancer Drug Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 GlaxoSmithKline Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Novartis
  5.4.2 Kidney Cancer Drug Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Novartis Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Pfizer
  5.5.2 Kidney Cancer Drug Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Pfizer Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Abbott Laboratories
  5.6.2 Kidney Cancer Drug Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Abbott Laboratories Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Active Biotech
  5.7.2 Kidney Cancer Drug Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Active Biotech Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Amgen
  5.8.2 Kidney Cancer Drug Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Amgen Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Argos Therapeutics
  5.9.2 Kidney Cancer Drug Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Argos Therapeutics Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 ArQule
  5.10.2 Kidney Cancer Drug Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 ArQule Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 AVEO Pharmaceuticals
5.12 Bionomics
5.13 Bristol-Myers Squibb
5.14 Cerulean Pharma
5.15 Exelixis
5.16 Genentech
5.17 immatics biotechnologies
5.18 Immunicum
5.19 Ono Pharmaceutical
5.20 Onyx Therapeutics
5.21 Oxford BioMedica
5.22 Prometheus Laboratories
5.23 Seattle Genetics
5.24 Taiwan Liposome
5.25 TRACON Pharmaceuticals
5.26 Wilex

6 KIDNEY CANCER DRUG MANUFACTURING COST ANALYSIS

6.1 Kidney Cancer Drug Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Kidney Cancer Drug

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Kidney Cancer Drug Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Kidney Cancer Drug Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES KIDNEY CANCER DRUG MARKET FORECAST (2016-2021)

10.1 United States Kidney Cancer Drug Sales, Revenue Forecast (2016-2021)
10.2 United States Kidney Cancer Drug Sales Forecast by Type (2016-2021)
10.3 United States Kidney Cancer Drug Sales Forecast by Application (2016-2021)
10.4 Kidney Cancer Drug Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Kidney Cancer Drug
Table Classification of Kidney Cancer Drug
Figure United States Sales Market Share of Kidney Cancer Drug by Type in 2015
Table Application of Kidney Cancer Drug
Figure United States Sales Market Share of Kidney Cancer Drug by Application in 2015
Figure United States Kidney Cancer Drug Sales and Growth Rate (2011-2021)
Figure United States Kidney Cancer Drug Revenue and Growth Rate (2011-2021)
Table United States Kidney Cancer Drug Sales of Key Manufacturers (2015 and 2016)
Table United States Kidney Cancer Drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Kidney Cancer Drug Sales Share by Manufacturers
Figure 2016 Kidney Cancer Drug Sales Share by Manufacturers
Table United States Kidney Cancer Drug Revenue by Manufacturers (2015 and 2016)
Table United States Kidney Cancer Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Kidney Cancer Drug Revenue Share by Manufacturers
Table 2016 United States Kidney Cancer Drug Revenue Share by Manufacturers
Table United States Market Kidney Cancer Drug Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Kidney Cancer Drug Average Price of Key Manufacturers in 2015
Figure Kidney Cancer Drug Market Share of Top 3 Manufacturers
Figure Kidney Cancer Drug Market Share of Top 5 Manufacturers
Table United States Kidney Cancer Drug Sales by Type (2011-2016)
Table United States Kidney Cancer Drug Sales Share by Type (2011-2016)
Figure United States Kidney Cancer Drug Sales Market Share by Type in 2015
Table United States Kidney Cancer Drug Revenue and Market Share by Type (2011-2016)
Table United States Kidney Cancer Drug Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Kidney Cancer Drug by Type (2011-2016)
Table United States Kidney Cancer Drug Price by Type (2011-2016)
Figure United States Kidney Cancer Drug Sales Growth Rate by Type (2011-2016)
Table United States Kidney Cancer Drug Sales by Application (2011-2016)
Table United States Kidney Cancer Drug Sales Market Share by Application (2011-2016)
Figure United States Kidney Cancer Drug Sales Market Share by Application in 2015
Table United States Kidney Cancer Drug Sales Growth Rate by Application (2011-2016)
Figure United States Kidney Cancer Drug Sales Growth Rate by Application (2011-2016)
Table Bayer Basic Information List
Table Bayer Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer Kidney Cancer Drug Sales Market Share (2011-2016)
Table F. Hoffmann-La Roche Basic Information List
Table F. Hoffmann-La Roche Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table F. Hoffmann-La Roche Kidney Cancer Drug Sales Market Share (2011-2016)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Kidney Cancer Drug Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Kidney Cancer Drug Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Kidney Cancer Drug Sales Market Share (2011-2016)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott Laboratories Kidney Cancer Drug Sales Market Share (2011-2016)
Table Active Biotech Basic Information List
Table Active Biotech Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Active Biotech Kidney Cancer Drug Sales Market Share (2011-2016)
Table Amgen Basic Information List
Table Amgen Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Amgen Kidney Cancer Drug Sales Market Share (2011-2016)
Table Argos Therapeutics Basic Information List
Table Argos Therapeutics Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Argos Therapeutics Kidney Cancer Drug Sales Market Share (2011-2016)
Table ArQule Basic Information List
Table ArQule Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table ArQule Kidney Cancer Drug Sales Market Share (2011-2016)
Table AVEO Pharmaceuticals Basic Information List
Table AVEO Pharmaceuticals Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table AVEO Pharmaceuticals Kidney Cancer Drug Sales Market Share (2011-2016)
Table Bionomics Basic Information List
Table Bionomics Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bionomics Kidney Cancer Drug Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Kidney Cancer Drug Sales Market Share (2011-2016)
Table Cerulean Pharma Basic Information List
Table Cerulean Pharma Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Cerulean Pharma Kidney Cancer Drug Sales Market Share (2011-2016)
Table Exelixis Basic Information List
Table Exelixis Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Exelixis Kidney Cancer Drug Sales Market Share (2011-2016)
Table Genentech Basic Information List
Table Genentech Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Genentech Kidney Cancer Drug Sales Market Share (2011-2016)
Table immatics biotechnologies Basic Information List
Table immatics biotechnologies Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table immatics biotechnologies Kidney Cancer Drug Sales Market Share (2011-2016)
Table Immunicum Basic Information List
Table Immunicum Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Immunicum Kidney Cancer Drug Sales Market Share (2011-2016)
Table Ono Pharmaceutical Basic Information List
Table Ono Pharmaceutical Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ono Pharmaceutical Kidney Cancer Drug Sales Market Share (2011-2016)
Table Onyx Therapeutics Basic Information List
Table Onyx Therapeutics Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Onyx Therapeutics Kidney Cancer Drug Sales Market Share (2011-2016)
Table Oxford BioMedica Basic Information List
Table Oxford BioMedica Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Oxford BioMedica Kidney Cancer Drug Sales Market Share (2011-2016)
Table Prometheus Laboratories Basic Information List
Table Prometheus Laboratories Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Prometheus Laboratories Kidney Cancer Drug Sales Market Share (2011-2016)
Table Seattle Genetics Basic Information List
Table Seattle Genetics Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Seattle Genetics Kidney Cancer Drug Sales Market Share (2011-2016)
Table Taiwan Liposome Basic Information List
Table Taiwan Liposome Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Taiwan Liposome Kidney Cancer Drug Sales Market Share (2011-2016)
Table TRACON Pharmaceuticals Basic Information List
Table TRACON Pharmaceuticals Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table TRACON Pharmaceuticals Kidney Cancer Drug Sales Market Share (2011-2016)
Table Wilex Basic Information List
Table Wilex Kidney Cancer Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Wilex Kidney Cancer Drug Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Kidney Cancer Drug
Figure Manufacturing Process Analysis of Kidney Cancer Drug
Figure Kidney Cancer Drug Industrial Chain Analysis
Table Raw Materials Sources of Kidney Cancer Drug Major Manufacturers in 2015
Table Major Buyers of Kidney Cancer Drug
Table Distributors/Traders List
Figure United States Kidney Cancer Drug Production and Growth Rate Forecast (2016-2021)
Figure United States Kidney Cancer Drug Revenue and Growth Rate Forecast (2016-2021)
Table United States Kidney Cancer Drug Production Forecast by Type (2016-2021)
Table United States Kidney Cancer Drug Consumption Forecast by Application (2016-2021)